Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,187 | 37,814 | 50,454 | 30,713 | N/A |
| Marketable Securities | 90,116 | 72,238 | N/A | N/A | N/A |
| Receivables | 5,857 | 9,267 | 7,426 | 3,745 | N/A |
| Other current assets | 0 | 0 | 1,946 | 0 | 0 |
| TOTAL | $166,644 | $128,301 | $65,589 | $36,288 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 13,364 | 6,297 | 6,206 | 7,458 | N/A |
| Intangibles | 11,650 | 12,780 | 13,100 | 13,420 | 0 |
| Other Non-Current Assets | 759 | 1,596 | 404 | 411 | 0 |
| TOTAL | $25,773 | $20,673 | $19,710 | $21,289 | $N/A |
| Total Assets | $192,417 | $148,974 | $85,299 | $57,577 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,248 | 2,373 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 38,814 | 25,644 | 17,511 | 1,440 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 7,256 | N/A |
| Other current liabilities | 1,336 | 1,153 | 125 | 454 | N/A |
| TOTAL | $57,734 | $38,520 | $26,151 | $16,325 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 103,427 | 37,482 | N/A | N/A | N/A |
| Deferred Revenues | 9,336 | 9,350 | 7,712 | 6,462 | N/A |
| Other Non-Current Liabilities | 7,835 | 8,097 | 1,992 | 809 | 0 |
| TOTAL | $178,148 | $116,971 | $80,839 | $68,932 | $N/A |
| Total Liabilities | $235,882 | $155,491 | $106,990 | $85,257 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,304 | 9,590 | N/A | N/A | N/A |
| Common Shares | 1,025 | 958 | 118 | 111 | N/A |
| Retained earnings | -572,245 | -442,116 | -350,839 | -271,616 | N/A |
| Other shareholders' equity | -24 | -38 | 268,799 | 192,284 | 0 |
| TOTAL | $-43,465 | $-6,517 | $-21,691 | $-27,680 | $N/A |
| Total Liabilities And Equity | $192,417 | $148,974 | $85,299 | $57,577 | $0 |